- Saxagliptin 2.5mg tablets
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Saxagliptin 2.5mg tablets | Start Date 04-03-2011 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- A10BH03
- BNF Codes
-
- BNF code 06010203
Code | Start Date | End Date |
---|---|---|
39703811000001106 | 26-05-2021 | |
443067000 | 07-03-2011 | 25-05-2021 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Saxagliptin hydrochloride | Based on Base Substance | Saxagliptin | 2.5 mg |
Name
Saxagliptin hydrochloride
Basis of strength description
Based on Base Substance
BOSS
Saxagliptin
Strength and UOM (Nmr)
2.5
Strength and UOM (Dmr)
Parent Products
-
VTMSaxagliptin
-
VMP(Current) Saxagliptin 2.5mg tablets
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
28 tablet | 3160 | Part VIIIA Category C |